-
Toulouse fall to first home defeat for a year
-
Global military spending surges on insecurity: report
-
Marseille see Champions League chance slip further away
-
Nelly Korda wins LPGA Chevron Championship
-
Syrian court begins proceedings against Assad and allies
-
Colombia road bombing death toll rises to 20
-
Raptors top Cavs to pull level in NBA playoff series
-
Iran minister heads to Russia as talks remain stalled
-
Rinku stars as Kolkata edge Lucknow in Super Over
-
T'Wolves Edwards to miss several weeks - report
-
Michael Jackson biopic debuts atop N. America box office
-
King Charles state visit to US to go on as planned after shooting
-
Inter pegged back by Torino as Serie A title charge hits bump in road
-
Mali junta in crisis after minister killed, key city 'captured'
-
Dortmund down Freiburg to seal Champions League spot
-
McFarlane hails Chelsea 'character' after FA Cup semi-final win
-
Gunman sought to kill Trump, cabinet at gala dinner
-
Arsenal punish Lyon errors in Champions League semi
-
Suspect in US press gala shooting - what we know
-
Key US senator lifts block on Fed chair nominee
-
Attacks in Mali: What we know
-
Vollering wins women's Lige-Bastogne-Liege for 3rd time
-
Sinner motors on in Madrid as Gauff overcomes stomach bug
-
Fernandez sends Chelsea into FA Cup final to lift gloom after Rosenior sacking
-
Colombia road bombing death toll rises to 19
-
Stuttgart stumble against Bremen in top-four race
-
Two former Israel PMs unite to challenge Netanyahu in elections
-
Trump says shooting proves need for his White House ballroom
-
Pogacar cracks teen Seixas to win 4th Liege-Bastogne-Liege
-
Iran minister returns to Pakistan despite US talks cancellation
-
Rabada's 3-25 helps Gujarat thrash Chennai in IPL
-
Pogacar beats teen Seixas to win 4th Liege-Bastogne-Liege
-
Gunman planned to target top Trump officials: attorney general
-
Alex Marquez wins Spanish MotoGP to end Bezzecchi streak
-
History-maker Sawe shatters marathon glass ceiling
-
Gauff overcomes stomach bug to beat Cirstea in Madrid
-
Mali defence minister killed, fresh fighting between army and rebels
-
Sawe makes history with first sub-two-hour marathon in London
-
Assefa wins London Marathon in women's-only world record time
-
Superstar galloper Ka Ying Rising storms to 20th straight win
-
Austria's Wiesberger wins first DP World Tour title in 1,792 days
-
Cummins hails teen wonder Sooryavanshi as 'my new favourite player'
-
New fighting in Mali's Kidal between army and rebels
-
Chernobyl refugee town welcomes Ukraine's conflict displaced
-
World leaders react to Washington gala shooting
-
Zelensky accuses Russia of 'nuclear terrorism' on Chernobyl anniversary
-
Coach says 'glimmer of hope' for imperilled Moana Pasifika
-
'I've studied assassinations': Trump muses on reasons for latest shooting
-
What we know about the Trump press gala shooting
-
Al Ahli made to 'suffer' in winning Asian Champions League: coach
DataMetrex Management Announces Strategic Plan
TORONTO, ON / ACCESS Newswire / February 27, 2025 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) is pleased to provide an update on its strategic direction with its commitment to focusing on healthcare and AI businesses.
As part of its growth initiatives, Datametrex plans to bolster its healthcare sector by expanding its clinic operations to meet a broader range of healthcare needs, including family medicine, walk-in examinations, and care by a specialist. The expansion will take place primarily via Mergers and Acquisitions (M&A), which the Company has identified numerous targets to roll up, and consolidate operations to lower the overhead costs and boost profits. The Company's clinic services will also be strengthened with wellness offerings, including IV therapy, Botox, and laser treatments. In alignment with this expansion, the Company plans to acquire additional clinics and their associated properties.
The Company has decided to wind down its non-core business, such as pharmacy and mobile gaming, to focus solely on healthcare and AI, as part of its deep and narrow strategy.
As part of this strategy, the Company will initiate industry consolidation through the acquisition and integration of multiple clinics and properties. This approach aims to strengthen the Company's portfolio by expanding its network of healthcare facilities.
Datametrex will continue to focus on its AI business. It is pleased to announce that the cash flows from AI service operations have remained strong through the Company's active and strategic management and customer acquisition. The Company is committed to further expanding its market presence, optimizing its AI solutions, and exploring new partnerships to drive sustainable growth in this sector.
Looking ahead, Datametrex intends to pursue a corporate restructuring plan that will split the Company into two entities, allowing for a distinct focus on healthcare and AI business operations. This initiative is expected to enhance operational efficiency and create greater value for shareholders.
Paul Haber, CEO of Datametrex, commented, "Our company is dedicated to strengthening our focus on the healthcare and AI business and ensuring that our upcoming corporate restructuring enhances efficiency and aligns with the best interests of our shareholders. We appreciate your continued support and look forward to the next phase of our growth."
About Datametrex
Datametrex is an innovative leader in Technology Solutions, Artificial Intelligence, Healthcare, and Mobile Gaming. The Company excels in delivering tools and solutions that enhance operational efficiencies and business outcomes. With a commitment to innovation, Datametrex is dedicated to supporting enterprises by setting a new standard for business protocols through cutting-edge technology.
For more on Datametrex, please visit our Company website.
For Additional Information
Paul Haber, C.P.A., C.A., C.Dir
CEO & Chairman
[email protected]
(416) 318-6501
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains "forward-looking statements," which involve risks, uncertainties, and factors that could cause actual results to differ materially from those anticipated. These statements are not historical facts and are generally identified by words such as "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," and similar expressions. Such statements include expectations related to healthcare business and other Company plans.
While Datametrex believes the forward-looking information is reasonable as of the date of this release, these statements involve assumptions, risks, and uncertainties that could cause actual outcomes to differ. Key factors include general economic conditions, legislative and regulatory developments, access to capital, industry competition, and the Company's ability to execute its strategies. The Company does not undertake to update these statements, except as required by law. Readers are advised not to place undue reliance on forward-looking information.
Factors that could cause actual results to differ materially are detailed under "Risk Factors" in Datametrex's management's discussion and analysis and available on the Company's profile at www.sedarplus.ca.
This release does not constitute an offer to sell or a solicitation to buy, nor shall it constitute an offer, solicitation, or sale in any jurisdiction where such would be unlawful prior to registration or qualification under applicable securities laws. We seek Safe Harbor.
SOURCE: DataMetrex AI Ltd.
View the original press release on ACCESS Newswire
Ch.Kahalev--AMWN